Cargando…
A comparative analysis of high-throughput platforms for validation of a circulating microRNA signature in diabetic retinopathy
MicroRNAs are now increasingly recognized as biomarkers of disease progression. Several quantitative real-time PCR (qPCR) platforms have been developed to determine the relative levels of microRNAs in biological fluids. We systematically compared the detection of cellular and circulating microRNA us...
Autores principales: | Farr, Ryan J., Januszewski, Andrzej S., Joglekar, Mugdha V., Liang, Helena, McAulley, Annie K., Hewitt, Alex W., Thomas, Helen E., Loudovaris, Tom, Kay, Thomas W. H., Jenkins, Alicia, Hardikar, Anandwardhan A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4649912/ https://www.ncbi.nlm.nih.gov/pubmed/26035063 http://dx.doi.org/10.1038/srep10375 |
Ejemplares similares
-
Circulating microRNAs: Understanding the Limits for Quantitative Measurement by Real‐Time PCR
por: Hardikar, Anandwardhan A., et al.
Publicado: (2014) -
Continuous subcutaneous insulin infusion alters microRNA expression and glycaemic variability in children with type 1 diabetes
por: Scott, Emma S., et al.
Publicado: (2021) -
Comparative analysis of diagnostic platforms for measurement of differentially methylated insulin DNA
por: Farr, Ryan J., et al.
Publicado: (2019) -
Phlda3 regulates beta cell survival during stress
por: Bensellam, Mohammed, et al.
Publicado: (2019) -
MicroRNAs as Prognostic Markers in Acute Coronary Syndrome Patients—A Systematic Review
por: Barraclough, Jennifer Y., et al.
Publicado: (2019)